We are live on
!
Find out more
CC
Crosslink Capital Portfolio holdings
AUM
$1.02B
1-Year Est. Return
9.21%
This Fund
S&P 500
This Quarter
Est. Return
-32.5%
1 Year Est. Return
-9.21%
3 Year Est. Return
+105.26%
5 Year Est. Return
+96.6%
10 Year Est. Return
+1,227.91%
AUM
$346M
AUM Growth
-$185M
(-35%)
Cap. Flow
-$1.55M
Cap. Flow
% of AUM
-0.45%
Top 10 Holdings %
Top 10 Hldgs %
80.46%
Holding
22
New
–
Increased
10
Reduced
5
Closed
4
Top Buys
| 1 |
Lam Research
LRCX
|
+$10.3M |
| 2 |
Salesforce
CRM
|
+$8.76M |
| 3 |
Nutanix
NTNX
|
+$6.83M |
| 4 |
Twilio
TWLO
|
+$6.59M |
| 5 |
Euronet Worldwide
EEFT
|
+$4.62M |
Top Sells
| 1 |
Micron Technology
MU
|
+$19.9M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$9.97M |
| 3 |
Shopify
SHOP
|
+$5.07M |
| 4 |
Palo Alto Networks
PANW
|
+$4.93M |
| 5 |
Mercado Libre
MELI
|
+$4.3M |
Sector Composition
| 1 | Technology | 83.81% |
| 2 | Healthcare | 8.43% |
| 3 | Consumer Discretionary | 7.76% |
| 4 | Communication Services | 0% |
Similar funds
CAM
EFM
SVCP
MSA
GP
MCM
IAS
GSIS
Crosslink Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Crosslink Capital held 22 positions worth $346M, down 35% from $531M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Crosslink Capital's Q2 2022 filing shows 10 increased, 5 reduced and 4 closed positions. The largest sale was Micron Technology, an estimated $19.9M.
By sector, the portfolio is most concentrated in Technology at 84% of assets, up from 77% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Crosslink Capital added most to Lam Research in Q2 2022, an estimated $10.3M increase.
- Crosslink Capital's biggest Q2 2022 reduction was ZENDESK INC, cutting an estimated $9.97M.
- Crosslink Capital fully exited Micron Technology in Q2 2022, selling an estimated $19.9M.
- Crosslink Capital's ten largest holdings make up 80% of its $346M portfolio in Q2 2022.
- Crosslink Capital opened 0 new positions and closed 4 in Q2 2022.
- Crosslink Capital's portfolio value fell 35% quarter-over-quarter to $346M.
Based on Crosslink Capital's 13F filing for Q2 2022, filed 15 Aug 2022.